Cargando…
Targeting mTOR for cancer therapy
Mechanistic target of rapamycin (mTOR) is a protein kinase regulating cell growth, survival, metabolism, and immunity. mTOR is usually assembled into several complexes such as mTOR complex 1/2 (mTORC1/2). In cooperation with raptor, rictor, LST8, and mSin1, key components in mTORC1 or mTORC2, mTOR c...
Autores principales: | Hua, Hui, Kong, Qingbin, Zhang, Hongying, Wang, Jiao, Luo, Ting, Jiang, Yangfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612215/ https://www.ncbi.nlm.nih.gov/pubmed/31277692 http://dx.doi.org/10.1186/s13045-019-0754-1 |
Ejemplares similares
-
Complex roles of cAMP–PKA–CREB signaling in cancer
por: Zhang, Hongying, et al.
Publicado: (2020) -
Mechanisms for estrogen receptor expression in human cancer
por: Hua, Hui, et al.
Publicado: (2018) -
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
por: Jiang, Yangfu, et al.
Publicado: (2022) -
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019) -
Gamma synuclein is a novel Twist1 target that promotes TGF-β-induced cancer cell migration and invasion
por: Shao, Ting, et al.
Publicado: (2018)